We are proud to announce the Inaugural Wearable Injectors and Connected Devices USA Conference taking place on the 13th and 14th of September 2023.
Following the success of the
Wearable Injectors and Connected Devices Europe conference, the only industry conference focusing on connected on body delivery systems, we will be bringing the conference to Boston to cater to Big Pharma, Biotech and Device Developers in the USA.
As the need for at home self-administration and routes for delivery of time-dependent and high-volume drug delivery grows, on-body
injectors and connected devices hold great opportunity. The conference will delve into on-body device design and development whilst also exploring the latest advances in connectivity and digital integration of wearable devices. Opportunities for enhancement of user-interface will also be explored.
As part of our leading international conference series on injectable delivery, we bring together high-level experts from big pharma and device developers to network and share knowledge to advance R&D. The two day conference will not only bring you high-quality key insights needed to enhance your
wearable devices and connected product portfolio but will also give you the opportunity to network with key players throughout the industry. We hope to welcome you to this must attend event in September 2023!
Benefits of Attending
- Engage in design strategy approaches for connected drug delivery devices with patient centricity at the forefront
- Listen to key regulatory updates surrounding digital health and medical devices and best practices for compliance
- Discover advances in device design and development for large volume delivery via on-body injectors
- Explore the key drivers of the industry, including the growing development of highly viscous drugs accelerating the development of on-body injectors
- Hear insights into the growing potential of digital health to improve patient experience and treatment
Who should attend
Executives, Directors, VPs, Heads, Principals, Managers of:
- Device Development
- Combination Product Development
- Smart Packaging
- Smart Devices
- Drug Delivery
- Connected/Digital Health
Speakers
- Alexandra Benbadis, Usability Leader, Sanofi
- Alicia Douglas, Human Factors Lead, Merck
- Anthony Coston, Technical Lead, Biogen
- Catharine Strom, Director, Global Regulatory Affairs, Device and Combination Products, Sanofi
- Christine Lynn Lanning, Distinguished Scientist, Merck & Co., Inc
- Claire Everitt, Design Engineering Team Lead, Pfizer
- E Guan, Head of Injection Systems, Takeda
- Jamie Tsung, Director of Drug Product Development, Alnylam
- Jeanne Greathouse, Global Director Healthcare, BSI Group
- Jessica Mastropietro, Device Development Engineer, Regeneron Pharmaceuticals Inc
- Jessica Wilkerson, Cyber Policy Advisor and Medical Device Cybersecurity Team Lead, FDA
- Leya Bergquist, Associate Director, UserWise
- Ling Zheng, Assoicate Director, Alexion Pharmaceuticals Inc
- Paul Upham, Head, Smart Devices, Roche/Genentech
- Peter Dorski, Associate Director, Janssen, Pharmaceutical Companies of Johnson and Johnson
- Samir Shah, Director, AstraZeneca
- Simon Wilson, Device Development Lead, Pfizer
- Sujani Nannapaneni, Senior Principal Research Scientist, Human Factors, AbbVie, Inc
Please fill in your name and email to receive the Conference Agenda of this event.
Venue
Sheraton Boston Hotel
39 Dalton Street,
Boston, MA, USA
